Cognate interaction plays a key role in the surveillance of autoreactive B cells in induced mixed bone marrow chimerism in BXSB lupus mice

References

• Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem cell transplantation. Nature. 2005; 435:620–627.
   PubMed Web of Science ®Google Scholar
• Wang BY, El-Badri NS, Good RA, Cherry (sic). Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation. Proc Nat Acad Sci USA. 1997; 94:12065–12069.
   Google Scholar
• Wang B, Yamamoto Y, El-Badri N, Good RA. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc Natl Acad Sci USA. 1999; 96:3012–3016.
   PubMed Web of Science ®Google Scholar
• Jones OY, Steele A, Jones JM, Marikar Y, Chang Y, Feliz A, Cahill RA, Good RA. Nonmyeloablative bone marrow transplantation of BXSB lupus mice using fully matched allogeneic donor cells from green fluorescent protein transgenic mice. J Immunol. 2004; 172:5415–5419.
   PubMed Web of Science ®Google Scholar
• Takeuchi E, Takeuchi Y. Allogeneic mixed chimerism induced by nonlymphoablative regimen including donor BMT with low-dose TBI and anti-CD40L cured proliferative glomerulonephritis in lupus mice. Ann NY Acad Sci. 2007; 1110:362–367.
   Google Scholar
• Mathieu C, Casteels K, Bouillon R, Waer M. Protection against autoimmune diabetes in mixed bone marrow chimeras. J Immunol. 1997; 158:1453–1457.
   Google Scholar
• Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989; 169:493–502.
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Ito H, Kurtz J, Wekerle T, Ho L, Sykes M. Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. Am J Transpl. 2004; 4:31–40.
   Google Scholar
• Banfi G, Mazzucco G, DiBelgiojoso GB, Bosiso MB, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G. Morphological parameters in lupus nephritis: Their relevance for classification and relationship with clinical and histological findings and outcome. Q J Med. 1985; 55 217: 153–168.
   Google Scholar
• Nossent H, Berden J, Swaak T. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritus. Lupus. 2000; 9:504–510.
   Google Scholar
• Nikolic B, Takeuchi Y, Leykin I, Fudaba Y, Neal Smith R, Sykes M. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes. 2004; 53:376–383.
   PubMed Web of Science ®Google Scholar
• Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 1979; 22:1188–1194.
   PubMed Web of Science ®Google Scholar
• Amano H, Amano E, Moll T, Marinkovic D, Ibonou-Zekri N, Martinez-Soria E, Semac I, Wirth T, Nitschke L, Izui S. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol. 2003; 170:2293–2301.
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigen due to TLR7 gene duplication. Science. 2006; 312 16: 1669–1672.
   Google Scholar
• Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, Liang C, MaDaniel LD, Zhou XJ, Schultz RA, Wakeland EK. A TLR7 translocation accelerates systemic autoimmunity in murine lupus. Proc Nat Acad USA. 2006; 103 26: 9970–9975.
   PubMed Web of Science ®Google Scholar
• Fossati L, Sobel ES, Iwamoto M, Cohen PL, Eisenberg RA, Izui S. The Yaa gene-mediated acceleration of murine lupus: Yaa− T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo. Eur J Immunol. 1995; 25:3412–3417.
   PubMed Web of Science ®Google Scholar
• Merino R, Fossati L, Lacour M, Izui S. Selective autoantibody production by Yaa+ B cells in autoimmune Yaa+-Yaa− bone marrow chimeric mice. J Exp Med. 1991; 174:1023–1029.
   PubMed Web of Science ®Google Scholar
• Izui S, Merino R, Fossati L, Iwamoto M. The role o the Yaa gene in lupus syndrome. Int Rev Immunol. 1994; 11:211–230.
   PubMedGoogle Scholar
• Fairhurst AM, Hwang SH, Wang A, Tian XH, Boudreax C, Zhou XJ, Casco J, Li QZ, Connolly JE, Wakeland EK. Yaa autoimmune phenotypes are conferred by over expression of TLR7. Eur J Immunol. 2008; 38:1971–1978.
   PubMed Web of Science ®Google Scholar
• Wofsy D. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J Immunol. 1986; 136:4554–4560.
   PubMed Web of Science ®Google Scholar
• Smith HR, Chused TM, Smithers PA, Steinberg AD. Evidence for thymic regulation of autoimmunity in BXSB mice: Acceleration of disease by neonatal thymectomy. J Immunol. 1983; 130:1200–1204.
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-Ligands modulated by the B cell antigen receptor. Cell. 1996; 87:319–329.
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature. 1995; 376:181–184.
   PubMed Web of Science ®Google Scholar
• Shinohara N, Komano H, Lee MH, Tachibana M, Iwata M. CD4+ T cells, positive selection, and surveillance of autoantibody production. The Immunologist. 1997; 5/4:121–126.
   Google Scholar
• Ikehara S, Good RA, Nakamura T, Sekita K, Inoue S, Oo MM, Muso E, Ogawa K, Hamashima Y. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Nat Acad Sci USA. 1985; 82:2483–2487.
   PubMed Web of Science ®Google Scholar
• Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F. BAFF and MyD88 signals promote a lupus like disease independent of T cells. J Exp Med. 2007; 204:1959–1971.
   PubMed Web of Science ®Google Scholar
• Mathieu C, Casteels K, Bouillon R, Wear M. Protection against autoimmune diabetes in mixed bone marrow chimeras. J Immunol. 1997; 158:1453–1457.
   Google Scholar
• Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in non-obese diabetic (NOD) mice. J Immunol. 1996; 156:380–388.
   PubMed Web of Science ®Google Scholar